LOGIN  |  REGISTER
Recursion

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

October 05, 2023 | Last Trade: US$10.83 0.16 -1.46

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
09/30/2023

 
96,253,553

 
 

Total gross of voting rights: 96,253,553

 
 

Total net* of voting rights: 96,076,898

 

* Net total = total number of voting rights attached to shares – shares without voting rights = 96,253,553 – 176,655 = 96,076,898

C4 Therapeutics

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page